Sandostatin

Product NDC

0078-0183

11-digit product format

000780183

Labeler code

0078

Product ID

0078-0183_d58922e6-487d-4a6c-ae2e-278fa0a47678

Type

HUMAN PRESCRIPTION DRUG

Nonproprietary name

octreotide acetate

Dosage form

INJECTION, SOLUTION

Route

INTRAVENOUS; SUBCUTANEOUS

Labeler

Novartis Pharmaceuticals Corporation

Application

NDA019667

Marketing category

NDA

Marketing start

1988-10-21

Marketing end

2019-07-31

Substance

OCTREOTIDE ACETATE

Active strength

200 ug/mL

Pharmacologic classes

Somatostatin Analog [EPC],Somatostatin Receptor Agonists [MoA]

NDC exclude flag

No

Listing certified through

0000-00-00

Current FDA listing

Historical FDA.report record